What is Vertex Pharmaceuticals's short-term investments?

Vertex Pharmaceuticals (VRTX) reported short-term investments of $1.52B in Q4 2025.

How has Vertex Pharmaceuticals's short-term investments changed year-over-year?

Vertex Pharmaceuticals's short-term investments decreased by 1.5% year-over-year, from $1.55B to $1.52B.

What is the long-term trend for Vertex Pharmaceuticals's short-term investments?

Over 5 years (2020 to 2025), Vertex Pharmaceuticals's short-term investments has grown at a 17.8% compound annual growth rate (CAGR), from $670.71M to $1.52B.

What does short-term investments mean?

Investments like stocks or bonds that the company plans to sell or cash out within the next twelve months.

Current Assets

Short-Term Investments

Vertex Pharmaceuticals Short-Term Investments increased by 13.1% to $1.52B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $1.55B to $1.52B. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows an upward trend with a 17.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryLiquidity

SignalHigher is better

VolatilityModerate

First reportedQ3 2018

Last reportedQ4 2025

How to read this metric

Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.

Detailed definition

Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...

Peer comparison

Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.

Metric ID: short_term_investments

Historical Data

19 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25
Value	$644.32M	$685.19M	$729.90M	$638.00M	$551.20M	$599.20M	$274.50M	$1.12B	$1.09B	$818.00M	$849.20M	$1.01B	$1.22B	$1.29B	$1.55B	$1.53B	$1.41B	$1.35B	$1.52B
QoQ Change	—	+6.3%	+6.5%	-12.6%	-13.6%	+8.7%	-54.2%	+309.5%	-3.5%	-24.6%	+3.8%	+19.3%	+19.9%	+5.8%	+20.3%	-1.3%	-7.6%	-4.5%	+13.1%
YoY Change	—	—	—	—	-14.5%	-12.5%	-62.4%	+76.2%	+96.9%	+36.5%	+209.4%	-9.9%	+12.0%	+57.1%	+82.1%	+50.6%	+16.1%	+4.8%	-1.5%

Range$274.50M – $1.55B

CAGR+21.1%

Avg YoY Growth+36.1%

Median YoY Growth+16.1%

Short-Term Investments at Other Companies

AbbVieABBV View metric

Bristol-Myers SquibbBMY View metric

PfizerPFE View metric

Gilead SciencesGILD View metric

Eli LillyLLY View metric

Merck & Co.MRK View metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's short-term investments?: Vertex Pharmaceuticals (VRTX) reported short-term investments of $1.52B in Q4 2025.
How has Vertex Pharmaceuticals's short-term investments changed year-over-year?: Vertex Pharmaceuticals's short-term investments decreased by 1.5% year-over-year, from $1.55B to $1.52B.
What is the long-term trend for Vertex Pharmaceuticals's short-term investments?: Over 5 years (2020 to 2025), Vertex Pharmaceuticals's short-term investments has grown at a 17.8% compound annual growth rate (CAGR), from $670.71M to $1.52B.
What does short-term investments mean?: Investments like stocks or bonds that the company plans to sell or cash out within the next twelve months.